The document discusses the impact of nanotechnology on cosmetics, highlighting over 125 products utilizing nanomaterials as of September 2008. It addresses the potential risks and regulatory challenges posed by nano-sized materials, which may alter exposure risks and cross the boundary between cosmetics and drugs. Action points include the need for clear criteria for defining nanomaterials and enhanced transparency and knowledge-sharing in the industry.